Loretta Young
 |
 220513CR WAMPAS BABY STARS LORETTA YOUNG HELEN FOSTER JANUARY 10 1929 NEWSPAPER $35.00 Time Remaining: 28d 20h 39m Buy It Now for only: $35.00 |
 Loretta Young Melvyn Douglas HE STAYED FOR BREAKFAST LOBBY CARD ORIGINAL 1940 $6.49 Time Remaining: 35m Buy It Now for only: $9.99 |
 Tyrone Power Loretta Young Cafe Metropole 1937 ORIGINAL scene still $11.99 Time Remaining: 15d 23h 40m Buy It Now for only: $11.99 |
 Vintage Loretta Young 38 GORGEOUS SPANISH LACE Gown Publicity Portrait $49.95 Time Remaining: 6h 47m |
 Vintage Loretta Young 38 GORGEOUS BEAUTY Portrait $49.95 Time Remaining: 17d 7h 22m Buy It Now for only: $49.95 |
 LORETTA YOUNG PHOTOGRAPH $9.99 Time Remaining: 29d 5h 57m Buy It Now for only: $9.99 |
 Film Star LORETTA YOUNG PHOTOS 150+ Pictures Rare Vintage ALBUM Collection $15.98 Time Remaining: 4h Buy It Now for only: $17.99 |
 Vintage Loretta Young 38 GORGEOUS BEAUTY Publicity Portrait $74.95 Time Remaining: 23d 23h 35m Buy It Now for only: $74.95 |
 Vintage Studio Photo LORETTA YOUNG ORIGINAL $9.00 Time Remaining: 4h 8m |
 LORETTA YOUNG vintage 1942 candid MB PAUL stamped PHOTO $24.95 Time Remaining: 4d 5h 41m Buy It Now for only: $24.95 |
 LE COUTEAU DANS LA PLAIE LORETTA YOUNG ANATOLE LITVAK 1962 MOVIE POSTER $140.00 Time Remaining: 29d 16h 22m Buy It Now for only: $140.00 |
 Tyrone Power Loretta Young Ladies in Love 1936 ORIGINAL on set photo $9.99 Time Remaining: 4d 1h 59m |
 LORETTA YOUNG plays piano Vintage 1944 8x10 Still Photo $9.29 Time Remaining: 17d 21h 55m Buy It Now for only: $9.29 |
 1937 Tyrone Power Loretta Young Love Is News PHOTO 170a $50.00 Time Remaining: 29d 1h 59m Buy It Now for only: $50.00 |
 Vintage 1937 Modern Screen Magazine Tyrone Power and Loretta Young August Neat $0.99 (1 Bid) Time Remaining: 1d 4h 36m |
 1946 Loretta Young The Perfect Marriage PHOTO 694e $25.00 Time Remaining: 13d 22h 28m Buy It Now for only: $25.00 |
 CHINA 1943 ALAN LADD LORETTA YOUNG WWII LOBBY $14.99 Time Remaining: 3h 38m |
 Loretta Young beautiful elegant portrait 1940s vintage movie photo 13973 $15.99 Time Remaining: 25d 16h 51m Buy It Now for only: $15.99 |
 LORETTA YOUNG BEAUTIFUL PORTRAIT $9.99 Time Remaining: 22d 5h 47m Buy It Now for only: $9.99 |
 THE RULING VOICE 1931 LORETTA YOUNG VINTAGE PHOTO W993 $24.99 Time Remaining: 7h 29m |
 Vintage Loretta Young 41 GORGEOUS ORNATE GOWN Publicity Portrait $49.95 Time Remaining: 17d 7h 22m Buy It Now for only: $49.95 |
 LORETTA YOUNG vintage 1946 THE STRANGER Film Noir PHOTO $9.95 Time Remaining: 4d 5h 41m Buy It Now for only: $9.95 |
 THE STRANGER LORETTA YOUNG EDWARD G ROBINSON ORIGINAL 1946 MOVIE AD $5.00 Time Remaining: 5h 44m |
 Loretta Young Conrad Veidt The Men in Her Life 1941 ORIG scene still DW $11.99 Time Remaining: 23d 18h 5m Buy It Now for only: $11.99 |
 FA31 Kentucky LORETTA YOUNG WALTER BRENNAN Lobby Card $16.00 Time Remaining: 7h 21m Buy It Now for only: $18.00 |
 Loretta Young Aline MacMahon Week End Marriage 1932 ORIGINAL scene still $11.99 Time Remaining: 27d 18h 9m Buy It Now for only: $11.99 |
 Vintage Loretta Young 41 GORGEOUS ORNATE GOWN Publicity Portrait $49.95 Time Remaining: 23d 23h 35m Buy It Now for only: $49.95 |
 ALAN LADD LORETTA YOUNG AND NOW TOMORROW 44 lobby card 7 $9.99 Time Remaining: 6h 24m Buy It Now for only: $30.00 |
 LORETTA YOUNG THE WHITE PARADE 30s VINTAGE PHOTO 436E $10.00 Time Remaining: 19d 36m Buy It Now for only: $10.00 |
 CLARK GABLE LORETTA YOUNG Call of the Wild R52 1 sheet fair G $9.99 Time Remaining: 6h 12m Buy It Now for only: $30.00 |
 Suez 38 Loretta Young Costume Original Photo $10.00 Time Remaining: 1d 12m Buy It Now for only: $10.00 |
 JEAN HARLOW LORETTA YOUNG ORIGINAL PLATINUM BLONDE MGM FILM STILL $20.00 Time Remaining: 27d 19h 26m Buy It Now for only: $20.00 |
 CLARK GABLE LORETTA YOUNG Call of the Wild R52 Jack Oakie 1 sheet G VG $9.99 Time Remaining: 6h 17m Buy It Now for only: $30.00 |
 ROBERT MITCHUM WILLIAM HOLDEN LORETTA YOUNG ORIG Photo $14.95 Time Remaining: 5d 9h 42m Buy It Now for only: $14.95 |
 LORETTA YOUNG LON CHANEY 8X11 Photo 28 RARE PORTRAIT $10.99 Time Remaining: 13d 16h 40m Buy It Now for only: $10.99 |
 Danish Film program Cary Grant Loretta Young D Niven $12.00 Time Remaining: 6h 7m |
 LORETTA YOUNG 8X11 Photo BW 1935 CRUSADES SHIMMERING GLITTER FASHION PORTRAIT $10.99 Time Remaining: 24d 21h 37m Buy It Now for only: $10.99 |
 GU17 He Stayed Breakfast LORETTA YOUNG Title Lobby Card $61.00 Time Remaining: 8h 1m Buy It Now for only: $70.00 |
 LORETTA YOUNG JOSEPH COTTEN Orig 1951 US Lobby Card HALF ANGEL $2.99 Time Remaining: 8d 19h 28m Buy It Now for only: $2.99 |
 LORETTA YOUNG 30s WIFE HUSBAND AND FRIEND PHOTO 697D $24.99 Time Remaining: 13d 16h 56m Buy It Now for only: $24.99 |
 Mon Film French Movie Magazine Nov 1949 Clark Gable Loretta Young Pierre Willm $5.00 Time Remaining: 1d 4h 38m |
 Loretta Young Original 8x10 Photo D5417 $14.99 Time Remaining: 7d 21h Buy It Now for only: $14.99 |
 LORETTA YOUNG 8X11 Photo BW 1941 SOUTHERN BELLE BEAUTY PORTRAIT RAY JONES $10.99 Time Remaining: 10d 4h 23m Buy It Now for only: $10.99 |
 Tommy Rettig with Loretta Young and Kent Smith original photo 1952 Paula $9.99 Time Remaining: 6h 28m |
 LORETTA YOUNG 8X11 Photo 1933 ZOO IN BUDAPEST Early SEXY PORTRAIT $10.99 Time Remaining: 10d 6h 51m Buy It Now for only: $10.99 |
 Loretta Young William Holden 2 Original 1940s Photos Robert Cummings $9.95 Time Remaining: 4d 5h 31m |
 They Call It Sin Loretta Young 1932 Photo Pre Code George Brent $12.00 Time Remaining: 27d 4m Buy It Now for only: $12.00 |
 Vintage 1960s Actress Loretta Young Glamour Photo 3 $9.88 Time Remaining: 3d 2h 24m Buy It Now for only: $9.88 |
 LORETTA YOUNG 5 Orig US Lobby Cards CLASSIC TITLES $19.99 (1 Bid) Time Remaining: 1d 6h 52m |
 Tyrone Power Loretta Young Annabella Suez ORIGINAL 1938 scene still $9.99 Time Remaining: 4d 5h 9m Buy It Now for only: $9.99 |
 Loretta Young Sexy Rare Portrait BW Photo 09 $13.50 Time Remaining: 5d 15h 55m Buy It Now for only: $13.50 |
 Vintage 1940 Movie Advertising Postage Stamp Meter Patent Envelope Loretta Young $7.00 Time Remaining: 2d 6h 8m Buy It Now for only: $8.00 |
 Loretta Young Sexy Rare Candid BW Photo 08 $13.50 Time Remaining: 5d 15h 53m Buy It Now for only: $13.50 |
 LORETTA YOUNG Color hand tinted Ross postcard 62 $10.00 Time Remaining: 8h 47m Buy It Now for only: $20.00 |
 LORETTA YOUNG vintage 1946 PARAMOUNT fashion PORTRAIT $49.95 Time Remaining: 4d 5h 41m Buy It Now for only: $49.95 |
 LORETTA YOUNG 1939 Rothmans ROUND Tobacco Card Beauties of the Cinema EX MT $14.79 Time Remaining: 29d 20h 58m Buy It Now for only: $14.79 |
 The Farmers Daughter Movie Lobby Card Set Loretta Young Joseph Cotten 1947 $0.99 (1 Bid) Time Remaining: 6d 31m |
 LORETTA YOUNG FAIRBANKS movie photo VITAPHONE 1929 $30.00 Time Remaining: 4d 23h 34m Buy It Now for only: $30.00 |
 LOVE IS NEWS Vintage 1937 TYRONE POWER LORETTA YOUNG Fox Insert Original POSTER $99.95 Time Remaining: 4d 7h 16m |
 Great portrait LORETTA YOUNG f13812 $39.99 Time Remaining: 27d 19h 23m Buy It Now for only: $39.99 |
 Vintage 1951 Loretta Young Cause Alarm Glamour Photo 2 $9.88 Time Remaining: 3d 2h 24m Buy It Now for only: $9.88 |
 1948 RACHEL AND THE STRANGER MOVIE AD Clipped NEWSPAPER LORETTA YOUNG $0.99 Time Remaining: 6h 38m |
 LORETTA YOUNG 1940s GLAMOUR FASHION PHOTOGRAPH $9.99 Time Remaining: 16d 6h 22m Buy It Now for only: $9.99 |
 1941 Loretta Young The Men In Her Life Movie PHOTO 661d $10.00 Time Remaining: 17d 21h 31m Buy It Now for only: $10.00 |
 Original Mexican Lobby Card The Crusades Loretta Young Wilcoxon Cecil B DeMille $12.99 Time Remaining: 6h 44m |
 LORETTA YOUNG WARNER BAXTER WIFE DOCTOR AND NURSE 158L $10.00 Time Remaining: 29d 5h 6m Buy It Now for only: $10.00 |
 LORETTA YOUNG 1930s De BEUKELAER movie star cookie wafer card $0.99 (1 Bid) Time Remaining: 4d 6h 30m |
 Conrad Veidt Loretta Young The Men in Her Life 1941 ORIGINAL scene still $11.99 Time Remaining: 6h 21m Buy It Now for only: $11.99 |
 Loretta Young Princess Margaret Sexy Rare Candid BW Photo $13.50 Time Remaining: 5d 15h 51m Buy It Now for only: $13.50 |
 1945 ALONG CAME JONES MOVIE AD Clipped NEWSPAPER GARY COOPER LORETTA YOUNG $0.99 Time Remaining: 11h 41m |
 LORETTA YOUNG Vintage Original Photo QUEEN NEFERTITI 1957 Rare SHOW PORTRAIT $29.99 Time Remaining: 25d 5h 41m Buy It Now for only: $29.99 |
 LORETTA YOUNG vintage 1941 CANDID on the set PHOTO $34.95 Time Remaining: 4d 5h 41m Buy It Now for only: $34.95 |
 HALF ANGEL 1951 LORETTA YOUNG JOSEPH COTTEN ORIGINAL 14X36 INSERT POSTER $9.99 Time Remaining: 4d 5h 7m |
 Loretta Young Original 8x10 Photo D6138 $14.99 Time Remaining: 22d 53m Buy It Now for only: $14.99 |
 Lon Chaney Loretta Young Laugh Clown Laugh 1928 Original vintage PHOTO $79.99 Time Remaining: 5d 5h 23m |
 LORETTA YOUNG THE MEN IN HER LIFE VINTAGE PHOTO Q953 $25.00 Time Remaining: 10d 3m Buy It Now for only: $25.00 |
 LORETTA YOUNGMELVYNN DOUGLASHe Stayed f13258 $39.99 Time Remaining: 13d 23h 12m Buy It Now for only: $39.99 |
 Loretta Young 2 Original 1949 Color Photos Mother is a Freshman Van Johnson $9.95 Time Remaining: 4d 5h 23m |
 LORETTA YOUNG ORSON WELLES Nice 8x10 Photo Noir $9.95 Time Remaining: 2d 23h 44m Buy It Now for only: $9.95 |
 5 STILLS WITH ORSON WELLES + LORETTA YOUNG IN THE STRANGER 1946 NAZI CRIME $224.95 Time Remaining: 4d 7h 25m Buy It Now for only: $249.95 |
 Loretta Young 8x10 Photo C5124 $9.99 Time Remaining: 21d 20h 44m Buy It Now for only: $9.99 |
 LORETTA YOUNG + JOHN BOLES 1934 8x10 Still Photo $9.29 Time Remaining: 17d 21h 55m Buy It Now for only: $9.29 |
 Vintage LORETTA YOUNG Picturegoer UK 1930s Postcard $7.99 Time Remaining: 6d 3h 40m |
 Loretta Young 8x10 Photo D1 $9.99 Time Remaining: 5d 9h 2m Buy It Now for only: $9.99 |
 LORETTA YOUNG Vintage 1948 Press Photo Rachel and the Stranger $10.29 Time Remaining: 17d 21h 55m Buy It Now for only: $10.29 |
 LORETTA YOUNG 1930s CLUB PRIVAT most beautiful woman german cigarette card $0.99 (1 Bid) Time Remaining: 6d 6h 21m |
 ORSON WELLES LORETTA YOUNG CANDID VINTAGE PHOTO 577C $25.00 Time Remaining: 15d 17h 9m Buy It Now for only: $25.00 |
 PRIVATE NUMBER Original Trade Ad ROBERT TAYLOR LORETTA YOUNG $5.95 Time Remaining: 6d 3h 19m |
 SEXY GLAMOUR LORETTA YOUNG VINTAGE PHOTO N450 $50.00 Time Remaining: 19h 21m Buy It Now for only: $50.00 |
 THE FARMERS DAUGHTER orig 8x10 Loretta Young $5.00 Time Remaining: 25d 8h 32m Buy It Now for only: $5.00 |
 Tommy Rettig with Loretta Young and Alexander Knox original photo 1952 Paula $9.99 Time Remaining: 4d 6h 30m |
 LORETTA YOUNG LIFE BEGINS 1932 VINTAGE PHOTO 411F $10.00 Time Remaining: 25d 2h 3m Buy It Now for only: $10.00 |
 1936 Loretta Young Robert Taylor Private Number 509Q $25.00 Time Remaining: 5d 3h 38m Buy It Now for only: $25.00 |
 Loretta Young Studio Movie Promotional Portrait Photo $7.99 Time Remaining: 5d 6h 52m |
 Lobby Cards Jack Palance Joan Fontaine Loretta Young Mickey Rooney Jack Carson $30.00 Time Remaining: 29d 1h 29m Buy It Now for only: $30.00 |
 Vintage Loretta Young Sepia Postcard 5 X 7 Hollywood Unused Rare EX Condition $2.00 Time Remaining: 5d 23h 1m |
 LORETTA YOUNG 8X10 PHOTO 3276 $9.95 Time Remaining: 11d 4h 40m Buy It Now for only: $9.95 |
 LORETTA YOUNG RARE ORIG STILL C7 $19.99 Time Remaining: 13d 13h 39m Buy It Now for only: $19.99 |
 Clark Gable Loretta Young Key to the City 1950 Modern Screen $9.25 Time Remaining: 4d 3h 9m |
 LORETTA YOUNG GORGEOUS CLOSE UP PHOTOGRAPH $9.99 Time Remaining: 10d 6h 24m Buy It Now for only: $9.99 |
Loretta Young
Stimulating the Body’s Defenses to Fight Ovarian Cancer
Comediennes such as Gilda Radner and Madeline Kahn, Oscar-winning actresses like Loretta Young and Sandy Dennis, singers Laura Nyro and Dinah Shore, actor Pierce Brosnan’s wife Cassandra Harris, actress Jessica Tandy, former Connecticut governor Ella Grasso, and Martin Luther King’s wife Coretta Scott King all died of ovarian cancer. It’s not just celebrities, politicians or movie stars, who are stricken with ovarian cancer. One in every 55 U.S. women is at risk for ovarian cancer. The American Cancer Society estimates about 22,000 new cases of ovarian cancer will be diagnosed. More than 16,000 women will die because the symptoms are often subtle, and her doctor did not recognize the symptoms soon enough. It is the leading cause of death from gynecologic malignancies, and the fifth leading cause of cancer deaths among women.
Silent and undetected, this cancer often spreads beyond the ovary or ovaries into the abdominal cavity, or by the final stage, into other body organs such as the liver or lungs. Family doctors often fail to properly diagnose “The Silent Killer” until it is too late. Last August, University of California Davis researchers reported 40 percent of women told their doctors about their symptoms for as long as a year before they were correctly diagnosed. A British survey discovered 75 percent of family doctors believed symptoms are only present during the advanced stages of the cancer. By the time women are diagnosed for ovarian cancer, 40 to 50 percent of the patients are in the advanced stage, where there is little hope for survival.
Less than one-half the women diagnosed with ovarian cancer will live five years. About 10 to 14 percent live beyond five years after their diagnosis. Their choices have been limited, mainly reserved to variations of chemotherapy drugs or a new way to delivery the drug. The general public is often unaware of the side effects ovarian cancer patients suffer during chemotherapy. In mid March, the U.S. Food and Drug Administration criticized the safety profile of Eli Lilly’s Gemzar for ovarian cancer patients, saying the 2.8 months increased survival seen in studies of patients taking the drug wasn’t enough to offset the treatment’s increased toxicity which included anemia, neutropenia (a blood disorder) and thrombocytopenia (reduced platelets in the blood). Presently used first-line treatments for ovarian cancer patients include Cisplatin, with associated side effects such as nerve, kidney and/or ear damage, Carboplatin (side effects: nerve damage in the arms and/or legs, joint pain, and/or thrombocytopenia), Paclitaxel (neurotoxicity), or Melphalan, with side effects which include irreversible bone marrow failure, bone marrow suppression).
A woman stricken with ovarian cancer faces first surgery, then chemotherapy. Recent widespread press heralding a new development in treating ovarian cancer, intra-abdominal or intraperitoneal chemotherapy, is just that: more chemotherapy. The “belly bath,” as it has been nicknamed by some television reporters, it has been highly praised because the treatment can extend life by about 16 months more than “regular” chemotherapy. The results were first published in the prestigious New England Journal of Medicine in December 2005. Most news reports failed to mention that only 40 percent of the women treated with the belly bath were able to complete all six cycles. Why? The therapy relies upon infusions of Paclitaxel and Cisplatin (see side effects in the previous paragraph). According to Dr. Robert Edwards, research director of the Magee-Women’s Gynecologic Cancer in Pittsburgh, “Many women don’t feel well enough to work for the duration of the intra-abdominal (therapy).” Some patients, such as Cindy Pakalnis of Marshall (Pennsylvania) have called the treatments “grueling.”
The unsolved problem of chemotherapy is the reduction in the “quality of life.” While some life extension has been proven, the patient’s life deteriorates. Many patients struggle with balancing the loss in quality of life with the rigors of the therapy. Researchers are actively pursuing new directions that may some day provide new hope for the ovarian cancer patient. A University of Minnesota research study has suggested the use of thalidomide, which would be used in conjunction with chemotherapy, as a prospective means of increasing the likelihood of remission. Minnesota cancer researcher Dr. Levi Downs explained, “It prevents the tumor from making new blood vessels. Without new blood vessels, the tumor can’t sufficiently feed new cells, so the cancer can’t grow.” His randomized trial was small with only 65 patients (only 28 took thalidomide), and more testing will certainly be required.
New Hope for Ovarian Cancer Patients?
One promising technology that has been developed over the past decade is OvaRex® MAb. It was developed by ViRexx Medical Corp., an Edmonton-based company, which trades on the American Stock Exchange (ticker symbol: REX) and on the Toronto Stock Exchange (ticker symbol: VIR). Now licensed to Unither Pharmaceuticals, a wholly owned subsidiary of United Therapeutics (NASDAQ: UTHR), OvaRex® MAb is currently undergoing two identical Phase III trials at about 64 research centers across the United States. One trial has completed enrollment, according to a mid December news release issued by ViRexx Medical Corp.
We spoke with ViRexx Medical Corp’s Chief Executive Officer, Dr. Tyrrell who was the Dean of the Faculty of Medicine and Dentistry at the University of Alberta and the Director of the Glaxo Heritage Research Institute. “OvaRex® MAb is our lead candidate for the treatment of ovarian cancer, and is an intravenous infusion of a monoclonal antibody,” he said. Monoclonal antibodies are a new breed of biotech drugs that are extremely specific; that is, each antibody binds to only one particular antigen. In the case of OvaRex® MAb, it is a monoclonal antibody that binds specifically to the CA-125 antigen. Dr. Tyrrell added, “The treatment doesn’t take long, and is given every 4 weeks for the first 3 injections, and then once every 3 months until the patient relapses”.
Dr. Tyrrell talked about the current Phase III studies, “The trials are ongoing. All of the patients have successfully completed their surgery and front-line chemotherapy and are now in what we call the ‘watchful waiting’ period. It is in this phase that we treat the patients with OvaRex® MAb with the hopes of increasing the time to disease relapse.” He explained the recurrence rate is very high in the stage III / IV late forms of ovarian cancer, with a time to relapse of about 10.4 months. Patients who have turned to OvaRex hope to delay that relapse. Tyrrell noted, “In the original study, the average time to relapse was delayed by about 14 months. If we can achieve that difference or better in the current Phase III trials, it would be a major advance for the treatment of ovarian cancer.” He expects an analysis of the current OvaRex® MAb studies to be completed by the second or third quarter of 2007.
What makes OvaRex® MAb different from other immunotherapeutic treatments is, instead of attacking the body’s cancerous cells directly, the monoclonal antibody targets the cancerous antigen in circulation. Some believe it helps retrain the body’s immune system to fight the ovarian cancer cells. The mechanism that reportedly has made OvaRex® MAb effective is how it alerts the body to recognize and fight the CA-125.
ViRexx has addressed the “tolerance problem” a body suffers when it has become inflicted with a malignant tumor. The hypothesis behind the tolerance issue is that the body fails to recognize the CA-125 antigen as harmful. Introducing a foreign antibody, in this case the mouse antibody against CA125, the body’s defense systems are awakened to the ovarian cancer cells. This begins a chain reaction alerting the immune system to battle the invading antibody CA125 complex. The body’s defense systems are reprogrammed to attack the CA-125 antigen and seek to destroy it. Along with that destruction comes the attempt of the immune response to eliminate the cancerous cells from the body.
As with many pioneering scientific breakthroughs, serendipity is what lies behind the OvaRex® MAb story. As one technology was being developed, another – the murine monoclonal antibody treatment for ovarian cancer – came about by accident. We talked to its inventor, Dr. Antoine Noujaim, about the biotech drug’s roots. “It came out of the imaging technology,” the Professor Emeritus of the University of Alberta explained. In the early 1980s, biotech companies, such as Immunomedics and Cytomedics were researching tumors and using antibodies to image the tumors so they could be evaluated in a cancer patient’s body. “I worked with Dr. Mike Longenecker and we established a company called Biomira (Toronto: BRA) in 1984,” Dr. Noujaim recalled. “We had a number of targets and then needed to make specific antibodies.” Part of his effort was to target certain cancers, such as prostate, breast and ovarian cancer.
“We developed antibodies against a mucin, which is really a glycopeptide,” explained Dr. Noujaim. “It’s a peptide that has a lot of sugars on it present in the ascitis fluid from ovarian cancer patients.” That is how Dr. Noujaim and his team developed the very early antibody which is now used for OvaRex® MAb. “We sent some of these antibodies to Professor Richard Baum in Germany for imaging of ovarian cancer patients,” Noujaim remembered. “Dr. Baum phoned back, after some time, and told me, ‘The patients I was imaging here had advanced ovarian cancer and some of them seem to have done quite well after we gave them a couple of shots (of the B43.13 antibody, the clinical name for OvaRex® MAb) to image the tumor.’ I thought he was joking with me.”
This is serendipity at work as Dr. Noujaim explained to us. “Richard was imaging patients that were in the last stages of the disease,” he pointed out. Monoclonal antibodies can be used as diagnostic agents in oncology, when they are radiolabeled with a marker that can be imaged by external detectors. “These patients had maybe four or five months to live. All of a sudden, a year later and they’re still around.” Baum urged Noujaim to investigate this further. Dr. Noujaim recalls him saying, “Something is happening here. I’ve seen hundreds of patients, but nothing like this.” From this encouragement, Noujaim began formulating the potential mechanism of how this monoclonal antibody would work. His sharp mind chased the puzzling questions raised by Dr. Baum’s observations.
At this point of his recollections, Noujaim got excited, “Through sheer serendipity, we were using murine antibodies, not humanized antibodies. We were using foreign antibodies, a small amount of foreign antibodies.” How in the world did Noujaim know to use murine (mouse) antibodies? “Because that was the easiest way to do the imaging at the time,” he replied. “Before you make a chimeric (something derived from two different animal species) antibody, you start with a murine one. If that one works, you humanize the antibody.” From this research, Noujaim founded a company called AltaRex, which was taken public in 1995. “We raised about $30 million and expanded the program.”
The serious effort to develop the antibodies began in 1996. Having conducted trials in Canada and Europe, it was a “massive undertaking” Noujaim told us. “We had over 500 patients injected with the murine monoclonal antibody.” He extrapolated beyond OvaRex® MAb, saying, “We’ve proven completely the mechanism of action on this, how it works. It is so unique it may apply to all of the other antibodies we have.” Noujaim believes it can apply to breast, ovarian, prostate and pancreatic cancer. Indeed, BrevaRex® MAb for breast cancer and multiple myeloma patients has completed Phase 1 trials, and ProstaRex® MAb for prostate cancer patients is at the pre-clinical stage.
“Our studies to date may show that vaccines may slow the growth of the tumor with a very good safety profile,” concluded Dr. Noujaim. Then he added something which bears investigating further, “There is the very original (ovarian cancer) patient who was injected in 1987. She’s in Germany, and according to Dr. Baum she was still alive a year ago.” That’s nearly nine years later! “It’s a matter of great pride for me that some people who received OvaRex® MAb are alive today,” he said.
While the company has licensed, under a royalty agreement, the OvaRex® MAb technology to United Therapeutics, through that company’s subsidiary, Unither Pharmaceuticals, ViRexx has retained rights to most member nations of the European Union and certain other countries. Key ones include France, the United Kingdom and the Benelux countries. ViRexx has also established strategic relationships with Dompé Farmaceutici, Medison Pharma, Ltd. and Genesis Pharma S.A. for certain European and Middle-East Countries.
http://www.cancer.moneybizhome.com
About the Author
Oli works full time as a Market Analyst.He graduated in Management.He can help you to grow your computer consulting.
http://www.moneybizhome.com/computers
Do women with thin or no eyebrows freak you out?
I did mine really thin: Loretta Young style!
Roz... well, I guess I am sorta a bit like a skank... so they fit! Yipee!
lol...your not skank. you just enjoy a good time. so, do i.
back to the question, women with thin or no eyebrows don't freak me out. i have thin eyebrows myself.
Loretta Young